Abstract
The treatment of retinopathy of prematurity (ROP) with intravitreal bevacizumab (IVB) has been associated with less myopia than laser. Due to concerns about late reactivation after treatment with IVB beyond conventional screening guidelines, completion of treatment with laser ablation to persistent avascular retina has been recommended. This study evaluates refractive outcomes comparing eyes treated with IVB and delayed laser (IVB-PRP) to eyes treated with primary laser (PRP).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Paper Title
Journal
Date
